PT  - JOURNAL ARTICLE
AU  - Auld, Sara C
AU  - Queiroz, Artur T L
AU  - Araujo-Pereira, Mariana
AU  - Maenetje, Pholo
AU  - Mofokeng, Nomsa
AU  - Mngomezulu, Lerato
AU  - Masilela, Duduzile
AU  - Dobosh, Brian
AU  - Tirouvanziam, Rabindra
AU  - Kornfeld, Hardy
AU  - Andrade, Bruno B
AU  - Bisson, Gregory P
TI  - Inflammatory profiles in sputum and blood of people with TB with and without HIV coinfection
AID  - 10.1101/2024.04.23.24306127
DP  - 2024 Jan 01
TA  - medRxiv
PG  - 2024.04.23.24306127
4099  - http://medrxiv.org/content/early/2024/04/24/2024.04.23.24306127.short
4100  - http://medrxiv.org/content/early/2024/04/24/2024.04.23.24306127.full
AB  - Although tuberculosis (TB) remains a major killer among infectious diseases and the leading cause of death for people with HIV, drivers of immunopathology, particularly at the site of infection in the lungs remain incompletely understood. To fill this gap, we compared cytokine profiles in paired plasma and sputum samples collected from adults with pulmonary TB with and without HIV. We found that people with pulmonary TB with HIV had significantly higher markers of inflammation in both plasma and sputum than those without HIV; these differences were present despite a similar extent of radiographic involvement. We also found that the strength and direction of correlations between biomarkers in the blood and lung compartments differed by HIV status and people with HIV had more positive correlations than those without HIV. Future studies can further explore these differences in inflammation by HIV status across the blood and lung compartments and seek to establish how these profiles may be associated with long-term outcomes and lung health after completion of TB treatment.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institute of Health with grants R01AI166988 [to SCA and GPB], K23AI134182 [to SCA], the Center for AIDS Research at University of Pennsylvania P30AI045008, and the Center for AIDS Research at Emory University P30AI050409.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Institutional Review Board of Emory University and the Health Research Ethics Counsel in South Africa approved this study. All participants provided written informed consent.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors